Black Diamond Therapeutics, Inc. (BDTX)
NASDAQ: BDTX · Real-Time Price · USD
1.610
+0.030 (1.90%)
At close: Apr 24, 2025, 4:00 PM
1.520
-0.090 (-5.59%)
Pre-market: Apr 25, 2025, 4:19 AM EDT
BDTX Employees
Black Diamond Therapeutics had 24 employees as of December 31, 2024. The number of employees decreased by 30 or -55.56% compared to the previous year.
Employees
24
Change (1Y)
-30
Growth (1Y)
-55.56%
Revenue / Employee
n/a
Profits / Employee
-$2,903,167
Market Cap
91.23M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novartis AG | 75,883 |
BDTX News
- 24 days ago - Black Diamond Therapeutics to Participate in Upcoming Investor Conferences - GlobeNewsWire
- 4 weeks ago - Black Diamond Therapeutics Trades Well Below Cash After Lucrative Deal With Servier - Seeking Alpha
- 5 weeks ago - Servier and Black Diamond Therapeutics Announce Global Licensing Agreement for BDTX-4933, A Targeted Oncology Therapy - GlobeNewsWire
- 6 weeks ago - Black Diamond Therapeutics: In Decline, But Why? - Seeking Alpha
- 7 weeks ago - Black Diamond Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Corporate Update - GlobeNewsWire
- 4 months ago - Black Diamond Therapeutics: Speculative Buy With Precision Oncology Catalysts - Seeking Alpha
- 6 months ago - Black Diamond Therapeutics Reports Third Quarter 2024 Financial Results and Provides Corporate Update - GlobeNewsWire
- 7 months ago - Black Diamond: EGFRm NSCLC Targeting Continues With Q1 Of 2025 Data - Seeking Alpha